Sort
50,496 grants matching “lung cancer”
Spermine N1-Acetylase Induction in Lung Cancers
$384,225Johns Hopkins University · R01 · FY2003 · CA
Spermine N1-Acetylase Induction in Lung Cancers
$384,225Johns Hopkins University · R01 · FY2005 · CA
Biomedical Applications of Expanded Porphyrins
$384,208Jonathan L. Sessler · University Of Texas At Austin · R01 · FY2024 · CA
Exploring the role of estrogen receptor beta in progression and metastasis of Inflammatory breast cancer
$384,168Christoforos Thomas · University Of Pennsylvania · R01 · FY2020 · CA
Transcriptional regulation of goblet cell metaplasia
$384,150Vladimir V Kalinichenko · Cincinnati Childrens Hosp Med Ctr · R01 · FY2015 · HL
Exosomes in Cancer Therapy
$384,147Raghu Kalluri · University Of Tx Md Anderson Can Ctr · R01 · FY2021 · CA
Exosomes in Cancer Therapy
$384,147Raghu Kalluri · University Of Tx Md Anderson Can Ctr · R01 · FY2017 · CA
Investigaton of Small Regulatory RNAs in Tumor Development
$384,092Tyler E Jacks · Massachusetts Institute Of Technology · P01 · FY2007 · CA
IRS-1 Regulates Inflammatory Cell Recruitment in Lung Cancer
$384,088A. McGarry Houghton · Fred Hutchinson Cancer Research Center · R01 · FY2019 · CA
Methods and Tools for Integrating Pathomics Data into Cancer Registries
$384,048Joel H Saltz · State University New York Stony Brook · UG3 · FY2019 · CA
Discovery of Anticancer Drugs from Cyanophytes
$384,028Frederick Augustus Valeriote · Henry Ford Health System · R01 · FY2011 · CA
FLT-PET/CT AS BIOMARKER OF THERAPEUTIC RESPONSE IN PEMETREXED THERAPY FOR NON-SMALL CELL LUNG CANCER
$384,000Trustees Of The University Of Pennsylvania, The · · FY2014 · Department of Defense
Chemoprevention of lung cancer by targeting lonidamine to mitochondria
$383,991Ming You · Methodist Hospital Research Institute · R01 · FY2022 · CA
Chemoprevention of lung cancer by targeting lonidamine to mitochondria
$383,989Ming You · Methodist Hospital Research Institute · R01 · FY2023 · CA
Reduced-Order Constrained Optimization for Rapid IMRT and VMAT Treatment Planning
$383,930Richard J Radke · Rensselaer Polytechnic Institute · R01 · FY2012 · CA
Pulmonary Focused Foundations in Innovation and Scholarship (PuFFInS)
$383,929Carol A Feghali-Bostwick · Medical University Of South Carolina · T32 · FY2021 · HL
P. carinii Pneumonia Lung Damage: CD8-driven Cellular and Molecular Events
$383,920Francis Gigliotti · University Of Rochester · R01 · FY2008 · HL
Multiplexed nanoparticle delivery to increase CRISPR/Cas gene editing for enhanced cancer therapy
$383,887Daniel John Siegwart · Ut Southwestern Medical Center · R01 · FY2023 · CA
TGF&, PI3K and HER2 Pathways in Breast Cancer Metastasis
$383,886Joan Massague · Sloan-Kettering Inst Can Research · P01 · FY2018 · CA
Control of Breast Cancer Metastasis by Epstein-Barr Virus microRNA
$383,875Kazuko Nishikura · Wistar Institute · R01 · FY2015 · CA
Control of Breast Cancer Metastasis by Epstein-Barr Virus microRNA
$383,875Kazuko Nishikura · Wistar Institute · R01 · FY2014 · CA
Isoform Specificities of the Latent TGF-beta Binding Proteins in Lung
$383,854Daniel B Rifkin · New York University School Of Medicine · R01 · FY2009 · CA
The Role of Pdcd4 in Translation, Tumorigenesis and Tumor Progression
$383,850Nancy H. Colburn · Division Of Basic Sciences - Nci · ZIA · FY2013 · CA
The Role of AP-1 and Other Transcription Factors in Cancer Cause and Prevention
$383,850Nancy H. Colburn · Division Of Basic Sciences - Nci · ZIA · FY2013 · CA
Satisfaction of Search in Diagnostic Radiology
$383,842Kevin Staley Berbaum · University Of Iowa · R01 · FY2010 · EB